Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.
Antimicrobial agents and chemotherapy·2004
Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro.
Antimicrobial agents and chemotherapy·2002
Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.
The Journal of infectious diseases·2001
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632.
Antimicrobial agents and chemotherapy·2000
BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents.
Antimicrobial agents and chemotherapy·2000
TENG with SMIP nanocatalytic probes for au nanosol SERS/abs quantitative analysis of ultratrace 4-methylimidazole.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Albumin Pre-Coating Enhances Intracellular siRNA Delivery of Multifunctional Amphiphile/siRNA Nanoparticles [Retraction].
International journal of nanomedicine·2026
George Martin and Werner's Syndrome.
Cytogenetic and genome research·2026